These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 27015221)

  • 61. Is the concomitant use of clopidogrel and Proton Pump Inhibitors still associated with increased adverse cardiovascular outcomes following coronary angioplasty?: a systematic review and meta-analysis of recently published studies (2012 - 2016).
    Bundhun PK; Teeluck AR; Bhurtu A; Huang WQ
    BMC Cardiovasc Disord; 2017 Jan; 17(1):3. PubMed ID: 28056809
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Adverse clinical outcomes associated with a low dose and a high dose of aspirin following percutaneous coronary intervention: a systematic review and meta-analysis.
    Bundhun PK; Janoo G; Teeluck AR; Huang WQ
    BMC Cardiovasc Disord; 2016 Sep; 16(1):169. PubMed ID: 27590185
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Anti-beta2-glycoprotein I antibodies in pediatric systemic lupus erythematosus and antiphospholipid syndrome.
    von Scheven E; Glidden DV; Elder ME
    Arthritis Rheum; 2002 Aug; 47(4):414-20. PubMed ID: 12209489
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Coagulopathy as a complication of kidney biopsies in paediatric systemic lupus erythematosus patients with antiphospholipid syndrome.
    Nagata H; Sato M; Ogura M; Yoshikawa T; Yamamoto K; Matsumura S; Kano Y; Saida K; Sako M; Kamei K; Yoshioka T; Ogata K; Ito S; Ishikura K
    Nephrology (Carlton); 2018 Jun; 23(6):592-596. PubMed ID: 28976051
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Coronary artery bypass surgery compared with percutaneous coronary interventions in patients with insulin-treated type 2 diabetes mellitus: a systematic review and meta-analysis of 6 randomized controlled trials.
    Bundhun PK; Wu ZJ; Chen MH
    Cardiovasc Diabetol; 2016 Jan; 15():2. PubMed ID: 26739589
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome.
    Alpert D; Mandl LA; Erkan D; Yin W; Peerschke EI; Salmon JE
    Ann Rheum Dis; 2008 Mar; 67(3):395-401. PubMed ID: 17644539
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Transient visual symptoms in systemic lupus erythematosus and antiphospholipid syndrome.
    Giorgi D; David V; Afeltra A; Gabrieli CB
    Ocul Immunol Inflamm; 2001 Mar; 9(1):49-57. PubMed ID: 11262668
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Autoantibodies to types I and IV collagen and heart valve disease in systemic lupus erythematosus/antiphospholipid syndrome.
    Pardos-Gea J; Cortés-Hernández J; Castro-Marrero J; Balada E; Ordi-Ros J
    Clin Rheumatol; 2017 Jun; 36(6):1401-1406. PubMed ID: 28283766
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Decreased diffusion capacity on lung function testing in asymptomatic patients with systemic lupus erythematosus does not predict future lung disease.
    Elalouf O; Fireman E; Levartovsky D; Kaufman I; Rogovski O; Elkayam O; Caspi D; Paran D
    Lupus; 2015 Aug; 24(9):973-9. PubMed ID: 25595620
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Autologous hematopoietic stem cell transplantation in Systemic Lupus Erythematosus and antiphospholipid syndrome: A systematic review.
    Leone A; Radin M; Almarzooqi AM; Al-Saleh J; Roccatello D; Sciascia S; Khamashta M
    Autoimmun Rev; 2017 May; 16(5):469-477. PubMed ID: 28279836
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Comparison of lung perfusion scintigraphic findings in pulmonary thromboembolism in systemic lupus erythematosus, SLE plus antiphospholipid syndrome, and primary antiphospholipid syndrome.
    Aung W; Murata Y; Ishida R; Shibuya H
    Nucl Med Commun; 2000 Mar; 21(3):299-304. PubMed ID: 10823333
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Fatal myocardial infarction in an 8-year-old girl with systemic lupus erythematosus, Raynaud's phenomenon, and secondary antiphospholipid antibody syndrome.
    Miller DJ; Maisch SA; Perez MD; Kearney DL; Feltes TF
    J Rheumatol; 1995 Apr; 22(4):768-73. PubMed ID: 7791180
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Prevalence of the antiphospholipid syndrome and its effect on survival in 679 Chinese patients with systemic lupus erythematosus: a cohort study.
    Mok CC; Chan PT; Ho LY; Yu KL; To CH
    Medicine (Baltimore); 2013 Jul; 92(4):217-222. PubMed ID: 23793109
    [TBL] [Abstract][Full Text] [Related]  

  • 74. EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome.
    Drosos GC; Vedder D; Houben E; Boekel L; Atzeni F; Badreh S; Boumpas DT; Brodin N; Bruce IN; González-Gay MÁ; Jacobsen S; Kerekes G; Marchiori F; Mukhtyar C; Ramos-Casals M; Sattar N; Schreiber K; Sciascia S; Svenungsson E; Szekanecz Z; Tausche AK; Tyndall A; van Halm V; Voskuyl A; Macfarlane GJ; Ward MM; Nurmohamed MT; Tektonidou MG
    Ann Rheum Dis; 2022 Jun; 81(6):768-779. PubMed ID: 35110331
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Effectiveness and safety of selective and non - selective factor Xa inhibitors in antiphospholipid syndrome and systemic lupus erythematosus: anti - Xa - activity range].
    Seredavkina NV; Reshetnyak TM; Satybaldyeva MA; Kashnikova LN; Temnikova TA; Nasonov EL
    Ter Arkh; 2019 May; 91(5):19-25. PubMed ID: 32598672
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Hypocomplementemia in systemic lupus erythematosus and primary antiphospholipid syndrome: prevalence and clinical significance in 667 patients.
    Ramos-Casals M; Campoamor MT; Chamorro A; Salvador G; Segura S; Botero JC; Yagüe J; Cervera R; Ingelmo M; Font J
    Lupus; 2004; 13(10):777-83. PubMed ID: 15540510
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Prevalence and clinical significance of antiprothrombin antibodies in patients with systemic lupus erythematosus or with primary antiphospholipid syndrome.
    Muñoz-Rodríguez FJ; Reverter JC; Font J; Tàssies D; Cervera R; Espinosa G; Carmona F; Balasch J; Ordinas A; Ingelmo M
    Haematologica; 2000 Jun; 85(6):632-7. PubMed ID: 10870121
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Antiphospholipid antibodies and the risk of thrombocytopenia in patients with systemic lupus erythematosus: A systematic review and meta-analysis.
    Chock YP; Moulinet T; Dufrost V; Erkan D; Wahl D; Zuily S
    Autoimmun Rev; 2019 Nov; 18(11):102395. PubMed ID: 31520800
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Prognostic value of allelic variants affecting the hemostatic system in the development of antiphospholipid syndrome and kidney lesion in patients with systemic lupus erythematosus].
    Borisov EN; Krasnova TN; Samohodskaia LM; Ivanitskiĭ LV; Nikiforova NV; Mukhin NA
    Ter Arkh; 2014; 86(6):57-62. PubMed ID: 25095657
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Splicing machinery is profoundly altered in systemic lupus erythematosus and antiphospholipid syndrome and directly linked to key clinical features.
    Lopez-Pedrera C; Patiño-Trives AM; Cerdó T; Ortega-Castro R; Sanchez-Pareja I; Ibañez-Costa A; Muñoz-Barrera L; Ábalos-Aguilera MC; Ruiz-Vilchez D; Seguí Azpilcueta P; Espinosa M; Barbarroja N; Escudero-Contreras A; Castaño JP; Luque RM; Ortega R; Aguirre MA; Perez-Sanchez C
    J Autoimmun; 2023 Feb; 135():102990. PubMed ID: 36621176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.